Clinical Trial Update: eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating depression treatment to reduce diabetes risk has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Symptoms
• Dysthymic Disorder
• Insulin Resistance
• Major Depressive Disorder
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Indiana University | Conditions: Depression, Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-11-02